Phase III trial of methotrexate

Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin ...

The regimens of carboplatin plus paclitaxel (CP) and methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) were compared in patients with advanced ...

Phase III trial of weekly methotrexate or pulsed dactinomycin for low ...

The biweekly dactinomycin regimen has a higher CR rate than the weekly IM methotrexate regimen in low-risk GTN, a generally curable disease.

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for ...

While biweekly dactinomycin demonstrated a superior CR rate in this comparison to weekly methotrexate 30 mg/m2, several other methotrexate regimens have been in ...

Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin ...

The combination regimen of methotrexate, vinblastine, doxorubicin, and cisplatin and that of carboplatin and paclitaxel are reported to have ...

the phase 3, randomised controlled FINCH 3 trial

Results The primary endpoint was achieved by 81% of patients receiving FIL200+ MTX versus 71% receiving MTX (p<0.001). A significantly greater proportion ...

Randomized Phase III Trial of High–Dose-Intensity Methotrexate ...

This randomized trial evaluated antitumor activity of and survival asociated with high–dose-intensity chemotherapy with methotrexate, vinblastine, doxorubicin, ...

Tofacitinib versus Methotrexate in Rheumatoid Arthritis

We report the findings of a phase 3 study of monotherapy with tofacitinib, an oral Janus kinase inhibitor, as compared with methotrexate ...

A phase III randomised, double-blind, parallel-group study ...

Patients with moderate to severe RA despite MTX treatment were randomised to receive weekly dose of 50 mg of subcutaneous SB4 or ETN. The primary endpoint was ...

Randomised phase III study of neoadjuvant chemotherapy with ...

This study aimed to determine the clinical benefit of neoadjuvant methotrexate, doxorubicin, vinblastine, and cisplatin (MVAC) in patients with muscle-invasive ...

Clinical Trials Using Methotrexate - NCI

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine ...

We designed a randomized phase III trial to compare the efficacy of dd-MVAC or GC in MIBC perioperative (neoadjuvant or adjuvant) setting.

Etanercept and Methotrexate as Monotherapy or in Combination for ...

The Study of Etanercept and Methotrexate in Subjects with Psoriatic Arthritis (SEAM-PsA) trial was a 48-week phase III, multicenter, randomized, ...

Phase III Trial of Methotrexate, Vinblastine, Doxorubicin, and ...

Phase III Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin versus Carboplatin and Paclitaxel in Patients with Advanced Carcinoma ...

Phase III Trial of Methotrexate, Vinblastine, Doxorubicin, and ...

In: Cancer. 2004 ; Vol. 100, No. 8. pp. 1639-1645. ... Phase III Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin versus Carboplatin ...

Sarilumab plus methotrexate improves patient-reported outcomes in ...

In the MOBILITY phase III randomized controlled trial (RCT), sarilumab + methotrexate (MTX) treatment resulted in clinical improvements at 24 ...

MBCL-34. EFFICACY OF METHOTREXATE (MTX) ACCORDING TO ...

Abstract. ACNS0334, a Phase 3 trial, compared outcomes of children <36 months treated with intensive chemotherapy +/-high-dose methotrexate.

Re: International Phase III Trial Assessing Neoadjuvant Cisplatin ...

Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastin Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term ...

Randomized phase III trial of high-dose-intensity methotrexate ...

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human ...

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for ...

We did a randomised, open-label, phase 3 study at 97 medical centres in 20 countries. ... The primary endpoint was overall survival in the ...

Significant pain reduction with oral methotrexate in knee osteoarthritis

Significant pain reduction with oral methotrexate in knee osteoarthritis; results from the promote randomised controlled phase iii trial of treatment ...